Published ·
FDA guidance on NAC in dietary supplements
The FDA’s final guidance describes enforcement discretion for certain products labeled as dietary supplements that contain NAC.

The 2022 guidance
The August 2022 document addresses N-acetyl-L-cysteine (NAC). It explains that FDA intends to exercise enforcement discretion for certain products containing NAC that are labeled as dietary supplements.
Which products the policy addresses
The guidance applies to products that would otherwise be lawfully marketed dietary supplements if NAC were not excluded from the statutory definition and that have no other violations of the Federal Food, Drug, and Cosmetic Act.
